DANE DICKSON, MD, FOUNDER AND CEO OF TAPROOT HEALTH -Preview 2
Update: 2020-06-22
Description
Fewer than 4% of oncology patients ever make it onto a clinical trial. And these 4% may not even reflect the real-world patient experience.
How can we use real world data in a rigorous and thoughtful way to come up with new standards of evidence to help move innovation forward?
How can we use real world data in a rigorous and thoughtful way to come up with new standards of evidence to help move innovation forward?
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
